Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Vay Liang W. Go

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 6 November 2026

Matched on OpenAlex author ID A5030588811, A5109087336, A5109180275; NIH RePORTER profile ID 1901925. Sources: OpenAlex.

Their work

Papers
24 (first author 5, last author 3)
Trials
0
Grants
3
Labs led
1
Collaborators
85
Papers, trials and grants by year

2011: 3 papers, 1 grant · 2012: 3 papers · 2013: 2 papers · 2014: none · 2015: 3 papers · 2016: 3 papers, 1 grant · 2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: 4 papers · 2022: none · 2023: none · 2024: 2 papers, 1 grant · 2025: 1 paper

Papers 24

  1. Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancer. Co-author DOI 10.1038/s41598-024-82369-9↗
  2. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study. Co-author DOI 10.1007/s10620-024-08338-4↗
  3. Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer. Co-author DOI 10.1016/j.isci.2024.110027↗
  4. Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review. Co-author DOI 10.1097/mpa.0000000000001762↗
  5. Early Detection of Pancreatic Cancer: Applying Artificial Intelligence to Electronic Health Records. Last author DOI 10.1097/mpa.0000000000001882↗
  6. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal. Co-author DOI 10.1097/mpa.0000000000001920↗
  7. Progress on the role of reactive oxygen species-mediated tumor microenvironment in pancreatic cancer. First author PMID 33903881↗
  8. Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration. Co-author DOI 10.1016/j.ajpath.2016.09.012↗
  9. Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers. First author DOI 10.1097/mpa.0000000000000939↗
  10. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. Co-author DOI 10.1371/journal.pone.0184455↗
  11. Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer. First author DOI 10.1097/mpa.0000000000000531↗
  12. Early Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper. Co-author DOI 10.1097/mpa.0000000000000701↗
  13. Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. Co-author DOI 10.1186/s40364-016-0074-3↗
  14. The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome. First author DOI 10.1097/mpa.0000000000000257↗
  15. Early detection of sporadic pancreatic cancer: summative review. Co-author DOI 10.1097/mpa.0000000000000368↗
  16. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper. Last author DOI 10.1097/mpa.0000000000000369↗
  17. The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. Co-author DOI 10.1097/mpa.0b013e318264ccae↗
  18. Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells. Co-author DOI 10.1186/2162-3619-2-18↗
  19. Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Co-author DOI 10.1016/j.bbamcr.2011.12.008↗
  20. Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells. Co-author DOI 10.1097/mpa.0b013e318236f022↗
  21. OA04.02. Mechanisms of growth inhibition of pancreatic cancer by omega-3 polyunsaturated fatty acids First author DOI 10.1186/1472-6882-12-s1-o14↗
  22. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.ajpath.2010.11.058↗
  23. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Co-author DOI 10.1016/j.bbamcr.2011.05.003↗
  24. Pancreatic cancer prevention and the 2010 Dietary Guidelines for Americans. Last author DOI 10.1097/mpa.0b013e3182203e3c↗

Grants 3

  1. Core 1: Animal and Cell Model Core P01CA236585↗
  2. Animal Core P01CA163200↗
  3. UCLA Center for Excellence in Pancreatic Diseases P01AT003960↗

Closest collaborators

The 25 strongest of 85 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gary Guishan Xiao · 8 shared papers, 2012–2025 · strength 1.07
  2. Guido Eibl · 7 shared papers, 2 shared grants, 2011–2024 · strength 1.05
  3. Stephen Jacob Pandol · 4 shared papers, 2 shared grants, 2016–2024 · strength 1.05
  4. Jianzhou Liu · 5 shared papers, 2016–2025 · strength 0.78
  5. Juan Enrique Rozengurt · 2 shared grants, 2016–2024 · strength 0.77
  6. Barbara J. Kenner · 6 shared papers, 2015–2021 · strength 0.47
  7. Suresh T. Chari · 6 shared papers, 2015–2021 · strength 0.47
  8. Jing Li Huang · 3 shared papers, 2016–2024 · strength 0.43
  9. Yongwei Sun · 2 shared papers, 2024–2025 · strength 0.39
  10. Minwei Yang · 2 shared papers, 2024–2025 · strength 0.39
  11. Ann E. Goldberg · 4 shared papers, 2016–2021 · strength 0.36
  12. Laura J. Rothschild · 4 shared papers, 2016–2021 · strength 0.36
  13. Junchao Guo · 2 shared papers, 2024 · strength 0.36
  14. Junchao Guo · 2 shared papers, 2021–2025 · strength 0.35
  15. Oscar Joe Hines · 7 shared papers, 1 shared grant, 2011–2017 · strength 0.35
  16. Xufeng Tao · 2 shared papers, 2021 · strength 0.35
  17. Sudhir Srivastava · 4 shared papers, 2015–2021 · strength 0.31
  18. Ge Gao · 2 shared papers, 2021–2024 · strength 0.29
  19. Qian Zhang · 1 shared paper, 2025 · strength 0.23
  20. Jing Huang · 1 shared paper, 2025 · strength 0.23
  21. Anna S. Gukovskaya · 2 shared papers, 1 shared grant, 2011–2017 · strength 0.23
  22. William Arthur Hoos · 2 shared papers, 2021 · strength 0.21
  23. Wenchao Xu · 1 shared paper, 2024 · strength 0.20
  24. Dong Shang · 1 shared paper, 2024 · strength 0.20
  25. Anirban Maitra · 3 shared papers, 2015–2021 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.